SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma. Jang HB, Kim SA, Jung EK, Lee KH, et al. BMC Cancer 2025;25:1570.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jang HB, Kim SA, Jung EK, Lee KH, et al. SOX4 enhances tumor progression and cisplatin resistance in orthotopic mouse xenograft model of head and neck squamous cell carcinoma. BMC Cancer 2025;25:1570.
PMID: 41087978